Kristleifur Kristjansson
Keine laufenden Positionen mehr
Karriereverlauf von Kristleifur Kristjansson
Ehemalige bekannte Positionen von Kristleifur Kristjansson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EMBLA MEDICAL HF. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | 01.07.2022 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Gründer | 01.01.1995 | 01.01.2012 |
| Corporate Officer/Principal | 01.01.1995 | 01.01.2012 | |
| Skraeda ehf | Gründer | - | - |
Ausbildung von Kristleifur Kristjansson
| University of Iceland | Doctorate Degree |
Statistik
International
| Island | 5 |
Operativ
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EMBLA MEDICAL HF. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
| Skraeda ehf |
